AVTX
#2421
Avalo Therapeutics, Inc. - Common Stock
20.0 5 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.43%
Monthly Change
+1.88%
6 month change
+18.01%
Year Change
+112.85%
Previous Close
20.5 5
Open
20.0 5
Low
20.0 5
High
20.0 5
Volume
114
Financials
- Market Capitalization 1.08 B
- Employee 33
- Founded 2011
- CEO N/A
- Website www.avalotx.com
- Headquarter Delaware, United States
- FIGI BBG001QHW0Y8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.11
Price to sales ratio
4 125.96
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2388 |  SVRA Savara, Inc. - Common Stock | 5.49 USD | -2.14% | -0.90% | +4.17% | +67.89% | 1.13 B USD | ||
| 2415 |  SLDB Solid Biosciences Inc. - Common Stock | 10.13 USD | +4.22% | +8.46% | +27.26% | +77.72% | 1.09 B USD | ||
| 2428 |  CADL Candel Therapeutics, Inc. - Common Stock | 13.75 USD | +3.54% | +8.70% | +40.16% | +135.04% | 1.05 B USD | ||
| 2439 |  LXRX Lexicon Pharmaceuticals, Inc. - Common Stock | 2.32 USD | +0.43% | +5.94% | -2.52% | +105.31% | 1.03 B USD |
Frequently asked questions about Avalo Therapeutics, Inc. Common Stock
What is the Avalo Therapeutics, Inc. Common Stock stock price today?
The current price of Avalo Therapeutics, Inc. Common Stock (AVTX) is 20.05. Over the past 24 hours, the stock has changed by -2.43%. Follow the AVTX chart for real-time price dynamics.
What is the stock ticker of Avalo Therapeutics, Inc. Common Stock?
Avalo Therapeutics, Inc. Common Stock trades under the ticker AVTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Avalo Therapeutics, Inc. Common Stock stock going up?
AVTX has changed by +0.15% over the last week, +1.88% over the last month, and +112.85% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Avalo Therapeutics, Inc. Common Stock?
Avalo Therapeutics, Inc. Common Stock currently has a market capitalization of 1.08 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Avalo Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Avalo Therapeutics, Inc. Common Stock reported earnings of -0.83 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Avalo Therapeutics, Inc. Common Stock net income for the last quarter?
Avalo Therapeutics, Inc. Common Stock reported net income of -36.36 M for the last quarter. The previous quarter showed -19.63 M, which means net income changed by -85.22%.
How many employees does Avalo Therapeutics, Inc. Common Stock have?
As of the latest available data, Avalo Therapeutics, Inc. Common Stock has 33 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Avalo Therapeutics, Inc. Common Stock stock?
You can buy Avalo Therapeutics, Inc. Common Stock (AVTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Avalo Therapeutics, Inc. Common Stock stock?
Investing in Avalo Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVTX chart and related analysis on metatrader.com as part of your research.